|
Carrington, Coleman, Sloman & Blumenthal, LLP
July 22, 2026 This week Laboratory Corporation of America agreed to pay $14.5 million to settle False Claims Act allegations that it billed Medicare for unnecessary urine drug tests by routinely running and charging for both presumptive and definitive testing on the same sample under its “ToxAssure Comprehensive” panel. iMessage can’t be made HIPAA compliant no matter how you configure it, because Apple won’t sign a Business Associate Agreement, backs up messages to iCloud with keys stored on...
July 22, 2026 This week The Texas Supreme Court ruled that omissions claims under the Texas Health Care Program Fraud Prevention Act must prove materiality even though the statute never uses that word, holding that a defendant who disclosed its conduct and kept getting paid without objection had effectively negated any claim that the omitted pricing information mattered to the government’s payment decision. Express Scripts is suing Texas Attorney General Ken Paxton to block the full release...
July 22, 2026 This week HHS Secretary Robert F. Kennedy Jr. has stacked the FDA’s Pharmacy Compounding Advisory Committee with nine new members largely favorable to peptide use, just ahead of July meetings on whether compounding pharmacies can produce unproven peptides like BPC-157 that FDA scientists say lack sufficient evidence of safety and efficacy. OIG Advisory Opinion No. 26-15 concludes that a home health agency’s payment of per-hospital subscription fees for online referral management...